Financhill
Back

Stride, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
47

LRN
Stride, Inc.

Last Price:
$66.05
Seasonality Move:
11.5%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
47
Stride, Inc. (LRN) is a Sell

Is Stride, Inc. a Buy, Sell or Hold?

  • The current Stride, Inc. [LRN] share price is $66.08. The Score for LRN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • LRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LRN Stock Price Chart

What is Stride, Inc.'s stock price today?

  • The Stride, Inc. share price today is $66.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRN is experiencing slight selling pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

LRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.55 Sell
Relative Strength Index (14 RSI): 39.45 Sell
Chaikin Money Flow: -1153951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.15 - 65.33) Buy
Bollinger Bands (100): (77.07 - 161.47) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

LRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.8 Buy
20-day SMA: 63.53 Buy
50-day SMA: 86.93 Sell
200-day SMA: 128.96 Sell
8-day EMA: 64.97 Buy
20-day EMA: 66.44 Sell
50-day EMA: 83.75 Sell
200-day EMA: 114.49 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Stride, Inc. Earnings Growth & LRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.95 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Stride, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):